Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 77

1.

Positron emission tomography imaging in evaluation of MS pathology in vivo.

Högel H, Rissanen E, Vuorimaa A, Airas L.

Mult Scler. 2018 Aug 9:1352458518791680. doi: 10.1177/1352458518791680. [Epub ahead of print]

PMID:
30091657
2.

Vascular adhesion protein-1 is actively involved in the development of inflammatory lesions in rat models of multiple sclerosis.

Elo P, Tadayon S, Liljenbäck H, Teuho J, Käkelä M, Koskensalo K, Saunavaara V, Virta J, Veres TZ, Kiviniemi A, Saraste A, Marjamäki P, Airas L, Jalkanen S, Roivainen A.

J Neuroinflammation. 2018 May 1;15(1):128. doi: 10.1186/s12974-018-1152-2.

3.

Evaluation of Microglial Activation in Multiple Sclerosis Patients Using Positron Emission Tomography.

Airas L, Nylund M, Rissanen E.

Front Neurol. 2018 Mar 26;9:181. doi: 10.3389/fneur.2018.00181. eCollection 2018. Review.

4.

Hemophagocytic lymphohistiocytosis in 2 patients with multiple sclerosis treated with alemtuzumab.

Saarela M, Senthil K, Jones J, Tienari PJ, Soilu-Hänninen M, Airas L, Coles A, Saarinen JT.

Neurology. 2018 May 1;90(18):849-851. doi: 10.1212/WNL.0000000000005420. Epub 2018 Mar 30. No abstract available.

PMID:
29602914
5.

Microglial activation, white matter tract damage, and disability in MS.

Rissanen E, Tuisku J, Vahlberg T, Sucksdorff M, Paavilainen T, Parkkola R, Rokka J, Gerhard A, Hinz R, Talbot PS, Rinne JO, Airas L.

Neurol Neuroimmunol Neuroinflamm. 2018 Mar 6;5(3):e443. doi: 10.1212/NXI.0000000000000443. eCollection 2018 May.

6.

Humoral response to John Cunningham virus during pregnancy in multiple sclerosis.

Saraste M, Atula S, Hedman K, Hurme S, Jalkanen A, Sneck M, Surcel HM, Maghzi AH, Airas L.

Mult Scler Relat Disord. 2018 Apr;21:11-18. doi: 10.1016/j.msard.2018.02.008. Epub 2018 Feb 9.

7.

In Vivo PET Imaging of Adenosine 2A Receptors in Neuroinflammatory and Neurodegenerative Disease.

Vuorimaa A, Rissanen E, Airas L.

Contrast Media Mol Imaging. 2017 Nov 20;2017:6975841. doi: 10.1155/2017/6975841. eCollection 2017. Review.

8.

Severe neutropenia after rituximab-treatment of multiple sclerosis.

Rissanen E, Remes K, Airas L.

Mult Scler Relat Disord. 2018 Feb;20:3-5. doi: 10.1016/j.msard.2017.12.005. Epub 2017 Dec 12.

PMID:
29253744
9.

Botulinum toxin alleviates dysphagia of patients with inclusion body myositis.

Schrey A, Airas L, Jokela M, Pulkkinen J.

J Neurol Sci. 2017 Sep 15;380:142-147. doi: 10.1016/j.jns.2017.07.031. Epub 2017 Jul 24.

PMID:
28870555
10.

Evaluation of the Effect of Fingolimod Treatment on Microglial Activation Using Serial PET Imaging in Multiple Sclerosis.

Sucksdorff M, Rissanen E, Tuisku J, Nuutinen S, Paavilainen T, Rokka J, Rinne J, Airas L.

J Nucl Med. 2017 Oct;58(10):1646-1651. doi: 10.2967/jnumed.116.183020. Epub 2017 Mar 23.

PMID:
28336784
11.

Natalizumab treatment leads to an increase in circulating CXCR3-expressing B cells.

Saraste M, Penttilä TL, Airas L.

Neurol Neuroimmunol Neuroinflamm. 2016 Oct 24;3(6):e292. eCollection 2016 Dec.

12.

Imaging of microglial activation in MS using PET: Research use and potential future clinical application.

Airas L, Rissanen E, Rinne J.

Mult Scler. 2017 Apr;23(4):496-504. doi: 10.1177/1352458516674568. Epub 2016 Oct 22. Review.

PMID:
27760860
13.

Utilization of PET imaging in differential diagnostics between a tumefactive multiple sclerosis lesion and low-grade glioma.

Tarkkonen A, Rissanen E, Tuokkola T, Airas L.

Mult Scler Relat Disord. 2016 Sep;9:147-9. doi: 10.1016/j.msard.2016.07.016. Epub 2016 Jul 26.

PMID:
27645363
14.

Successive pregnancies in multiple sclerosis.

Gilmore W, Airas L.

Neurology. 2016 Sep 27;87(13):1316-7. doi: 10.1212/WNL.0000000000003039. Epub 2016 Jul 27. No abstract available.

PMID:
27466469
15.

Effect of Fingolimod-Treatment on Blood Lipid Profiles of Multiple Sclerosis Patients.

Hovi A, Airas L.

J Neuroimmune Pharmacol. 2016 Dec;11(4):611-612. Epub 2016 Jul 7. No abstract available.

PMID:
27388874
16.

Anti-JC virus seroprevalence in a Finnish MS cohort.

Kolasa M, Hagman S, Verkkoniemi-Ahola A, Airas L, Koivisto K, Elovaara I.

Acta Neurol Scand. 2016 May;133(5):391-7. doi: 10.1111/ane.12475. Epub 2015 Sep 8.

PMID:
26347001
17.

[Update on Current Care Guideline: Multiple sclerosis].

Remes A, Airas L, Atula S, Färkkilä M, Hartikainen P, Koivisto K, Mäenpää E, Ruutiainen J, Sumelahti ML; Päivitystiivistelmä.

Duodecim. 2015;131(5):500-1. Finnish.

PMID:
26237913
18.

Association between soluble L-selectin and anti-JCV antibodies in natalizumab-treated relapsing-remitting MS patients.

Basnyat P, Hagman S, Kolasa M, Koivisto K, Verkkoniemi-Ahola A, Airas L, Elovaara I.

Mult Scler Relat Disord. 2015 Jul;4(4):334-8. doi: 10.1016/j.msard.2015.06.008. Epub 2015 Jun 17.

PMID:
26195052
19.

Hormonal and gender-related immune changes in multiple sclerosis.

Airas L.

Acta Neurol Scand. 2015;132(199):62-70. doi: 10.1111/ane.12433. Review.

PMID:
26046561
20.

No evidence of human herpesvirus DNA in the CSF of multiple sclerosis patients.

Airas L, Säpyskä N, Broberg E.

Neurol Sci. 2015 Jun;36(6):1053-4. doi: 10.1007/s10072-015-2081-9. Epub 2015 Jan 23. No abstract available.

PMID:
25613860
21.

In vivo PET imaging demonstrates diminished microglial activation after fingolimod treatment in an animal model of multiple sclerosis.

Airas L, Dickens AM, Elo P, Marjamäki P, Johansson J, Eskola O, Jones PA, Trigg W, Solin O, Haaparanta-Solin M, Anthony DC, Rinne J.

J Nucl Med. 2015 Feb;56(2):305-10. doi: 10.2967/jnumed.114.149955. Epub 2015 Jan 8. Erratum in: J Nucl Med. 2015 Mar;56(3):495.

22.

Imaging neuroinflammation in multiple sclerosis using TSPO-PET.

Airas L, Rissanen E, Rinne JO.

Clin Transl Imaging. 2015;3:461-473. Epub 2015 Oct 19. Review.

23.

Automated reference region extraction and population-based input function for brain [(11)C]TMSX PET image analyses.

Rissanen E, Tuisku J, Luoto P, Arponen E, Johansson J, Oikonen V, Parkkola R, Airas L, Rinne JO.

J Cereb Blood Flow Metab. 2015 Jan;35(1):157-65. doi: 10.1038/jcbfm.2014.194. Epub 2014 Nov 5.

24.

Elevated concentration of C-reactive protein is associated with pregnancy-related co-morbidities but not with relapse activity in multiple sclerosis.

Jalkanen A, Kauko T, Koskinen JO, Waris ME, Airas L.

Neurol Sci. 2015 Mar;36(3):441-7. doi: 10.1007/s10072-014-1980-5. Epub 2014 Oct 12.

PMID:
25308726
25.

Multiple sclerosis and vitamin D during pregnancy and lactation.

Jalkanen A, Kauko T, Turpeinen U, Hämäläinen E, Airas L.

Acta Neurol Scand. 2015 Jan;131(1):64-7. doi: 10.1111/ane.12306. Epub 2014 Sep 12.

PMID:
25216350
26.

In Vivo Detection of Diffuse Inflammation in Secondary Progressive Multiple Sclerosis Using PET Imaging and the Radioligand ¹¹C-PK11195.

Rissanen E, Tuisku J, Rokka J, Paavilainen T, Parkkola R, Rinne JO, Airas L.

J Nucl Med. 2014 Jun;55(6):939-44. doi: 10.2967/jnumed.113.131698. Epub 2014 Apr 7.

27.

Labour-associated increase in C-reactive protein concentration is not predictive of postpartum relapse activity among mothers with multiple sclerosis.

Jalkanen A, Kauko T, Koskinen JO, Waris ME, Airas L.

Mult Scler. 2014 Nov;20(13):1790-1. doi: 10.1177/1352458514528764. Epub 2014 Apr 2. No abstract available.

PMID:
24696054
28.

Specific aspects of modern life for people with multiple sclerosis: considerations for the practitioner.

Oreja-Guevara C, Wiendl H, Kieseier BC, Airas L; NeuroNet Study Group.

Ther Adv Neurol Disord. 2014 Mar;7(2):137-49. doi: 10.1177/1756285613501575. Review.

29.

Detection of microglial activation in an acute model of neuroinflammation using PET and radiotracers 11C-(R)-PK11195 and 18F-GE-180.

Dickens AM, Vainio S, Marjamäki P, Johansson J, Lehtiniemi P, Rokka J, Rinne J, Solin O, Haaparanta-Solin M, Jones PA, Trigg W, Anthony DC, Airas L.

J Nucl Med. 2014 Mar;55(3):466-72. doi: 10.2967/jnumed.113.125625. Epub 2014 Feb 10.

30.

Clinical relevance of brain volume measures in multiple sclerosis.

De Stefano N, Airas L, Grigoriadis N, Mattle HP, O'Riordan J, Oreja-Guevara C, Sellebjerg F, Stankoff B, Walczak A, Wiendl H, Kieseier BC.

CNS Drugs. 2014 Feb;28(2):147-56. doi: 10.1007/s40263-014-0140-z. Review.

PMID:
24446248
31.

[Multiple sclerosis and pregnancy].

Ruuskanen J, Malm H, Airas L.

Duodecim. 2013;129(14):1457-64. Review. Finnish.

PMID:
23961604
32.

Adenosine A2A receptors in secondary progressive multiple sclerosis: a [(11)C]TMSX brain PET study.

Rissanen E, Virta JR, Paavilainen T, Tuisku J, Helin S, Luoto P, Parkkola R, Rinne JO, Airas L.

J Cereb Blood Flow Metab. 2013 Sep;33(9):1394-401. doi: 10.1038/jcbfm.2013.85. Epub 2013 May 22.

33.

Alteration of prolyl oligopeptidase and activated α-2-macroglobulin in multiple sclerosis subtypes and in the clinically isolated syndrome.

Tenorio-Laranga J, Peltonen I, Keskitalo S, Duran-Torres G, Natarajan R, Männistö PT, Nurmi A, Vartiainen N, Airas L, Elovaara I, García-Horsman JA.

Biochem Pharmacol. 2013 Jun 15;85(12):1783-94. doi: 10.1016/j.bcp.2013.04.018. Epub 2013 Apr 30.

PMID:
23643808
34.

Increased thyroid autoimmunity among women with multiple sclerosis in the postpartum setting.

Jalkanen A, Saraste M, Gfeller A, Surcel HM, Airas L.

Mult Scler. 2013 Nov;19(13):1734-42. doi: 10.1177/1352458513485148. Epub 2013 Apr 29.

PMID:
23629943
35.

Pregnancy and multiple sclerosis.

Airas L, Kaaja R.

Obstet Med. 2012 Sep;5(3):94-7. doi: 10.1258/om.2012.110014. Epub 2012 May 29. Review.

36.

Lower brain diffusivity in postpartum period compared to late pregnancy: results from a prospective imaging study of multiple sclerosis patients.

Paavilainen T, Kurki T, Färkkilä M, Salonen O, Parkkola R, Airas L.

Neuroradiology. 2012 Aug;54(8):823-8. doi: 10.1007/s00234-011-0994-4. Epub 2011 Dec 13.

PMID:
22160148
37.

Symptomatic therapy in multiple sclerosis: a review for a multimodal approach in clinical practice.

de Sa JC, Airas L, Bartholome E, Grigoriadis N, Mattle H, Oreja-Guevara C, O'Riordan J, Sellebjerg F, Stankoff B, Vass K, Walczak A, Wiendl H, Kieseier BC.

Ther Adv Neurol Disord. 2011 May;4(3):139-68. doi: 10.1177/1756285611403646.

38.

Janus head: the dual role of HLA-G in CNS immunity.

Huang YH, Airas L, Schwab N, Wiendl H.

Cell Mol Life Sci. 2011 Feb;68(3):407-16. doi: 10.1007/s00018-010-0582-5. Epub 2010 Nov 18. Review.

PMID:
21086150
39.

Reversible brain hypometabolism associated with central nervous system systemic lupus erythematosus.

Kemppainen J, Kajander S, Yli-Kerttula T, Airas L, Seppänen M.

Eur J Nucl Med Mol Imaging. 2011 Feb;38(2):411. doi: 10.1007/s00259-010-1652-5. Epub 2010 Nov 6. No abstract available.

PMID:
21057786
40.

Is the modulatory effect of pregnancy in multiple sclerosis associated with changes in blood apoptotic molecules?

Rinta S, Airas L, Elovaara I.

Acta Neurol Scand. 2010 Sep;122(3):168-74. doi: 10.1111/j.1600-0404.2009.01301.x.

PMID:
20695850
41.

Breast-feeding, postpartum and prepregnancy disease activity in multiple sclerosis.

Airas L, Jalkanen A, Alanen A, Pirttilä T, Marttila RJ.

Neurology. 2010 Aug 3;75(5):474-6. doi: 10.1212/WNL.0b013e3181eb5860. No abstract available.

PMID:
20679640
42.

Pregnancy outcome in women with multiple sclerosis: results from a prospective nationwide study in Finland.

Jalkanen A, Alanen A, Airas L; Finnish Multiple Sclerosis and Pregnancy Study Group.

Mult Scler. 2010 Aug;16(8):950-5. doi: 10.1177/1352458510372629. Epub 2010 Jun 11.

PMID:
20542921
43.

Carbon monoxide poisoning-induced nigrostriatal dopaminergic dysfunction detected using positron emission tomography (PET).

Rissanen E, Paavilainen T, Virta J, Marttila RJ, Rinne JO, Airas L.

Neurotoxicology. 2010 Aug;31(4):403-7. doi: 10.1016/j.neuro.2010.03.006. Epub 2010 Mar 24.

PMID:
20346372
44.

Development of an immunoassay for the detection of cystatin C dimers.

Hyytiä H, Ristiniemi N, Airas L, Pettersson K, Hellman J.

J Immunol Methods. 2010 Apr 15;355(1-2):14-20. doi: 10.1016/j.jim.2010.02.014. Epub 2010 Mar 2.

PMID:
20202469
45.

Central nervous system immune reconstitution inflammatory syndrome (IRIS) after hematopoietic SCT.

Airas L, Päivärinta M, Röyttä M, Karhu J, Kauppila M, Itälä-Remes M, Remes K.

Bone Marrow Transplant. 2010 Mar;45(3):593-6. doi: 10.1038/bmt.2009.186. Epub 2009 Aug 17. No abstract available.

PMID:
19684631
46.

CD73 is expressed on invading T lymphocytes in the inflamed peripheral nerve.

Meyer Zu Hörste G, Reiners J, Lehmann HC, Airas L, Kieseier BC.

Muscle Nerve. 2009 Aug;40(2):287-9. doi: 10.1002/mus.21325.

PMID:
19609917
48.

Apparent Diffusion Coefficient Histograms in the Follow-up of Relapsing-Remitting Multiple Sclerosis.

Paavilainen T, Kurki T, Korhonen K, Airas L.

Neuroradiol J. 2009 Mar 23;22(1):22-8. Epub 2009 Mar 23.

PMID:
24206949
49.

IFN-beta regulates CD73 and adenosine expression at the blood-brain barrier.

Niemelä J, Ifergan I, Yegutkin GG, Jalkanen S, Prat A, Airas L.

Eur J Immunol. 2008 Oct;38(10):2718-26. doi: 10.1002/eji.200838437.

50.

CD73 is required for efficient entry of lymphocytes into the central nervous system during experimental autoimmune encephalomyelitis.

Mills JH, Thompson LF, Mueller C, Waickman AT, Jalkanen S, Niemela J, Airas L, Bynoe MS.

Proc Natl Acad Sci U S A. 2008 Jul 8;105(27):9325-30. doi: 10.1073/pnas.0711175105. Epub 2008 Jun 30.

Supplemental Content

Support Center